Inventor
WATERFIELD MICHAEL
GB14 patents
⚠️ This page may combine multiple inventors who share the name “WATERFIELD MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LUDWIG INST CANCER RES
5 patentsUS7285531B1Oct 23, 2007
Method for prophylaxis or treatment of a nervous system, pathophysiological condition involving a glial growth factor sensitive cell by administration of a glial growth factor
LUDWIG INST CANCER RES7 citations72
US7135456B1Nov 14, 2006
Glial mitogenic factors, their preparation and use
LUDWIG INST CANCER RES8 citations72
US6972280B2Dec 6, 2005
Glial mitogenic factors, their preparation and use
LUDWIG INST CANCER RES5 citations72
US7192915B1Mar 20, 2007
Methods for treating multiple sclerosis with GGF-related polypeptides
LUDWIG INST CANCER RES1 citations61
US7094749B1Aug 22, 2006
Glial mitogenic factors, their preparation and use
LUDWIG INST CANCER RES4 citations61
CAMBRIDGE NEUROSCIENCE INC
4 patentsUS6147190ANov 14, 2000
Glial mitogenic factors, their preparation and use
CAMBRIDGE NEUROSCIENCE INC11 citations81
US5854220ADec 29, 1998
Glial mitogenic factors, their preparation and use
CAMBRIDGE NEUROSCIENCE INC9 citations81
US6194377B1Feb 27, 2001
Methods for treating nervous system pathophysiologies using glial growth factors
CAMBRIDGE NEUROSCIENCE INC1 citations61
US6204241B1Mar 20, 2001
Method for treating nervous system pathophysiologies using glial growth factors
CAMBRIDGE NEUROSCIENCE INC1 citations50
ACORDA THERAPEUTICS INC
3 patentsUS7319019B1Jan 15, 2008
Glial mitogenic factors lacking an N-terminal signal sequence
ACORDA THERAPEUTICS INC18 citations90
US7541338B2Jun 2, 2009
Glial mitogenic factors, their preparation and use
ACORDA THERAPEUTICS INC0 citations51
US7968678B2Jun 28, 2011
Glial mitogenic factors, their preparation and use
ACORDA THERAPEUTICS INC1 citations50